Stay updated on Nivolumab Dose Optimization Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Dose Optimization Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Dose Optimization Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added related topics links for Lung cancer and MedlinePlus Genetics on the study page.
    Difference
    0.3%
    Check dated 2025-11-03T14:23:11.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Lung cancer and MedlinePlus Genetics have been removed from the page's sections for conditions and related topics. This reduces the explicit disease context and access to related health resources on the study details page.
    Difference
    0.1%
    Check dated 2025-10-27T12:13:35.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed MedlinePlus Genetics topic on lung cancer, reducing coverage of that specific genetic/medical topic.
    Difference
    0.1%
    Check dated 2025-10-20T09:07:54.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a new MedlinePlus Genetics topic on Lung cancer to the page, expanding core content related to genetics and cancer.
    Difference
    0.1%
    Check dated 2025-10-13T06:56:15.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T04:27:11.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Add: new version label v3.1.0. Remove: old version label v3.0.2 and the topic tag 'Lung cancer' under MedlinePlus Genetics.
    Difference
    0.2%
    Check dated 2025-09-28T23:48:08.000Z thumbnail image

Stay in the know with updates to Nivolumab Dose Optimization Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Dose Optimization Clinical Trial page.